http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004013100-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5b0784eae5e6bc16d3fe3f9ad04d7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cfaf16a7f8bbdf81feb0f4e49fac1bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fe3eda65abb3a67d476967c917a1a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bddc653b60ee96f63cccbb67979d2fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0b629aa4273c4079247d5eac6ee7a0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a40b3917f0d6fb2d5a875db4851412d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0235a273c710b28f0d1a0dc5642ce04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
filingDate 2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee3c6ff137e9b850511e45885af97bba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe1e5995d58d474e02e58acb65ef882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90dc8f2aa68e2b3827a59db46798b5e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_965df60a4c11ab61d641d8490974ba42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e907346f42d0a3718363cf26debfd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b6e68528dfbdfe74bf1b1d9004ec442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff6e7cf767559761e411cdd8617396a
publicationDate 2004-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004013100-A3
titleOfInvention N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
abstract Disclosed are compounds of general formula (I) in which R1 represents H or an alkyl, cycloalkyl alkyl, phenylalkyl, alkenyl, or alkynyl, X represents H or one or several halogen atoms, alkyl, or alkoxy, R2 represents H or one or several halogen atoms or alkoxy groups, or optionally substituted amino, R3 represents an optionally substituted aminosulfonyl group, a cyano group or a group of formula S-alkyl, an alkylsulfonyl group, a carboxy or alkoxycarbonyl group, an optionally substituted carbamoyl group, an acetyl or benzoyl group, or an alkyl, cycloalkyl, alkenyl, phenyl, thienyl or thianthrenyl group. Said compounds are used for therapeutic purposes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9309200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9586945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9586942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238619-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9365512-B2
priorityDate 2002-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9945011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5254569-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570

Total number of triples: 36.